Viewing Study NCT01339104


Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2026-06-01 @ 4:02 AM
Study NCT ID: NCT01339104
Status: COMPLETED
Last Update Posted: 2014-10-01
First Post: 2011-04-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor Activity
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cardiovascular safety View